BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 30478527)

  • 1. Establishment of a transgenic mouse to model ETV7 expressing human tumors.
    Numata M; Klein Geltink RI; Grosveld GC
    Transgenic Res; 2019 Feb; 28(1):115-128. PubMed ID: 30478527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zebrafish ETV7 regulates red blood cell development through the cholesterol synthesis pathway.
    Quintana AM; Picchione F; Klein Geltink RI; Taylor MR; Grosveld GC
    Dis Model Mech; 2014 Feb; 7(2):265-70. PubMed ID: 24357328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Analysis of the ETS Family in Melanoma Reveals a Regulatory Role of ETV7 in the Immune Microenvironment.
    Qu H; Zhao H; Zhang X; Liu Y; Li F; Sun L; Song Z
    Front Immunol; 2020; 11():612784. PubMed ID: 33424867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETV6 and ETV7: Siblings in hematopoiesis and its disruption in disease.
    Rasighaemi P; Ward AC
    Crit Rev Oncol Hematol; 2017 Aug; 116():106-115. PubMed ID: 28693791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ETV7-Mediated DNAJC15 Repression Leads to Doxorubicin Resistance in Breast Cancer Cells.
    Alessandrini F; Pezzè L; Menendez D; Resnick MA; Ciribilli Y
    Neoplasia; 2018 Aug; 20(8):857-870. PubMed ID: 30025229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
    Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ETS factor TEL2 is a hematopoietic oncoprotein.
    Carella C; Potter M; Bonten J; Rehg JE; Neale G; Grosveld GC
    Blood; 2006 Feb; 107(3):1124-32. PubMed ID: 16234363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.
    Xing C; Ci X; Sun X; Fu X; Zhang Z; Dong EN; Hao ZZ; Dong JT
    Neoplasia; 2014 Nov; 16(11):883-99. PubMed ID: 25425963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ETV7 limits antiviral gene expression and control of influenza viruses.
    Froggatt HM; Harding AT; Chaparian RR; Heaton NS
    Sci Signal; 2021 Jul; 14(691):. PubMed ID: 34257104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid PTEN promotes inflammation but impairs bactericidal activities during murine pneumococcal pneumonia.
    Schabbauer G; Matt U; Günzl P; Warszawska J; Furtner T; Hainzl E; Elbau I; Mesteri I; Doninger B; Binder BR; Knapp S
    J Immunol; 2010 Jul; 185(1):468-76. PubMed ID: 20505137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
    Li C; Zheng X; Li W; Bai F; Lyu J; Meng QH
    BMC Cancer; 2018 Jan; 18(1):61. PubMed ID: 29316891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
    Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
    J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual Shp2 and Pten Deficiencies Promote Non-alcoholic Steatohepatitis and Genesis of Liver Tumor-Initiating Cells.
    Luo X; Liao R; Hanley KL; Zhu HH; Malo KN; Hernandez C; Wei X; Varki NM; Alderson N; Chu C; Li S; Fan J; Loomba R; Qiu SJ; Feng GS
    Cell Rep; 2016 Dec; 17(11):2979-2993. PubMed ID: 27974211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutual contribution of Pten and estrogen to endometrial carcinogenesis in a PtenloxP/loxP mouse model.
    Saito F; Tashiro H; To Y; Ohtake H; Ohba T; Suzuki A; Katabuchi H
    Int J Gynecol Cancer; 2011 Nov; 21(8):1343-9. PubMed ID: 21989218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN, more than the AKT pathway.
    Blanco-Aparicio C; Renner O; Leal JF; Carnero A
    Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype.
    Podsypanina K; Li Y; Varmus HE
    BMC Med; 2004 Jun; 2():24. PubMed ID: 15198801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial phosphatase and tensin homolog regulates intestinal architecture and secretory cell commitment and acts as a modifier gene in neoplasia.
    Langlois MJ; Roy SA; Auclair BA; Jones C; Boudreau F; Carrier JC; Rivard N; Perreault N
    FASEB J; 2009 Jun; 23(6):1835-44. PubMed ID: 19168705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ETV7 reduces inflammatory responses in breast cancer cells by repressing the TNFR1/NF-κB axis.
    Meškytė EM; Pezzè L; Bartolomei L; Forcato M; Bocci IA; Bertalot G; Barbareschi M; Oliveira-Ferrer L; Bisio A; Bicciato S; Baltriukienė D; Ciribilli Y
    Cell Death Dis; 2023 Apr; 14(4):263. PubMed ID: 37041130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific G-protein-coupled receptor collaborates with loss of PTEN to promote prostate cancer progression.
    Rodriguez M; Siwko S; Zeng L; Li J; Yi Z; Liu M
    Oncogene; 2016 Mar; 35(9):1153-62. PubMed ID: 26028029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma.
    Huang CF; Chen L; Li YC; Wu L; Yu GT; Zhang WF; Sun ZJ
    J Exp Clin Cancer Res; 2017 Sep; 36(1):116. PubMed ID: 28865486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.